Gentian Diagnostics ASA (OSL: GENT)
Norway
· Delayed Price · Currency is NOK 50.00
-2.50 (-4.76%)
Aug 30, 2024, 4:27 PM CET
Gentian Diagnostics ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 146.3 | 135.15 | 101.64 | 83.12 | 63.33 | 47.95 | Upgrade
|
| Other Revenue | 5.21 | 7.19 | 10.29 | 16.89 | 15.55 | 7.43 | Upgrade
|
| Revenue | 151.51 | 142.35 | 111.92 | 100.01 | 78.88 | 55.38 | Upgrade
|
| Revenue Growth (YoY) | 22.63% | 27.18% | 11.91% | 26.78% | 42.43% | 20.87% | Upgrade
|
| Cost of Revenue | 70.57 | 66.75 | 52.64 | 43.18 | 32.59 | 25.45 | Upgrade
|
| Gross Profit | 80.94 | 75.6 | 59.29 | 56.83 | 46.3 | 29.94 | Upgrade
|
| Selling, General & Admin | 44.92 | 40.79 | 37.42 | 34.35 | 31.32 | 26.46 | Upgrade
|
| Other Operating Expenses | 22.97 | 31.53 | 34.86 | 37.98 | 26.17 | 24.5 | Upgrade
|
| Operating Expenses | 78.42 | 81.89 | 82.52 | 79.68 | 64.12 | 57.09 | Upgrade
|
| Operating Income | 2.52 | -6.29 | -23.23 | -22.85 | -17.82 | -27.16 | Upgrade
|
| Interest Expense | -1.29 | -0.8 | -1.26 | -1.38 | - | - | Upgrade
|
| Interest & Investment Income | - | 2.67 | 1.11 | 0.09 | 0.6 | 2 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.6 | 0.6 | -0.2 | -0.6 | 0.29 | -0.22 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.91 | -0.08 | -0.05 | -0.06 | -0.54 | -0.32 | Upgrade
|
| EBT Excluding Unusual Items | 4.74 | -3.9 | -23.62 | -24.79 | -17.47 | -25.71 | Upgrade
|
| Asset Writedown | -6.47 | -6.47 | - | - | - | -14.09 | Upgrade
|
| Pretax Income | -1.73 | -10.37 | -23.62 | -24.79 | -17.47 | -39.79 | Upgrade
|
| Income Tax Expense | 0.28 | 0.28 | - | - | - | 0.06 | Upgrade
|
| Net Income | -2.01 | -10.65 | -23.62 | -24.79 | -17.47 | -39.86 | Upgrade
|
| Net Income to Common | -2.01 | -10.65 | -23.62 | -24.79 | -17.47 | -39.86 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | -0.31% | - | 0.05% | 0.06% | 0.01% | 0.05% | Upgrade
|
| EPS (Basic) | -0.13 | -0.69 | -1.53 | -1.61 | -1.13 | -2.59 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.69 | -1.53 | -1.61 | -1.13 | -2.59 | Upgrade
|
| Free Cash Flow | 11.43 | 14.5 | -22.59 | -28.08 | -15.24 | -22.45 | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 0.94 | -1.46 | -1.82 | -0.99 | -1.46 | Upgrade
|
| Gross Margin | 53.42% | 53.11% | 52.97% | 56.83% | 58.69% | 54.05% | Upgrade
|
| Operating Margin | 1.66% | -4.42% | -20.76% | -22.84% | -22.60% | -49.03% | Upgrade
|
| Profit Margin | -1.33% | -7.48% | -21.10% | -24.79% | -22.15% | -71.96% | Upgrade
|
| Free Cash Flow Margin | 7.55% | 10.19% | -20.18% | -28.07% | -19.32% | -40.54% | Upgrade
|
| EBITDA | 5.08 | -3.43 | -20.49 | -21.32 | -16.11 | -25.79 | Upgrade
|
| EBITDA Margin | 3.35% | -2.41% | -18.30% | -21.32% | -20.42% | -46.57% | Upgrade
|
| D&A For EBITDA | 2.56 | 2.87 | 2.75 | 1.53 | 1.71 | 1.36 | Upgrade
|
| EBIT | 2.52 | -6.29 | -23.23 | -22.85 | -17.82 | -27.16 | Upgrade
|
| EBIT Margin | 1.66% | -4.42% | -20.76% | -22.84% | -22.60% | -49.03% | Upgrade
|
| Revenue as Reported | 106.19 | 142.35 | 111.92 | 100.01 | 78.88 | 55.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.